e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Indoor and outdoor air quality considerations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Years of potential life lost due to malignant pleural mesothelioma in Turkey
S. Metintas (Eskisehir, Turkey), G. Ak (Eskisehir, Turkey), M. Metintas (Eskisehir, Turkey)
Source:
International Congress 2019 – Indoor and outdoor air quality considerations
Session:
Indoor and outdoor air quality considerations
Session type:
Thematic Poster
Number:
4446
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Metintas (Eskisehir, Turkey), G. Ak (Eskisehir, Turkey), M. Metintas (Eskisehir, Turkey). Years of potential life lost due to malignant pleural mesothelioma in Turkey. 4446
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Diagnosis and staging of malignant pleural mesothelioma
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Related content which might interest you:
Mesothelioma in situ with regressive malignant pleural effusion. A year latter
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021
Management of malignant pleural mesothelioma in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017
Malignant pleural mesothelioma (MPM) – 5 years of experience
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006
Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015
Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007
Variation in incidence trends of malignant pleural mesothelioma in Europe
Source: Eur Respir J, 51 (2) 1702384; 10.1183/13993003.02384-2017
Year: 2018
Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017
Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020
What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002
Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource
Source: Eur Respir J 2007; 30: 1021
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept